Sum­it­o­mo clinch­es My­ovant buy­out af­ter up­ping of­fer to $2.9B

A few weeks af­ter balk­ing at a buy­out of­fer, My­ovant Sci­ences ap­pears to have suc­cess­ful­ly ne­go­ti­at­ed up­ward.

The for­mer Vivek Ra­maswamy com­pa­ny ac­cept­ed a deal …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER